Smartphone App Found to Improve Monitoring of Huntington’s Disease Progression

Researchers from University College London (UCL) and pharmaceutical company Roche have found that smartphone-based digital tests may improve the detection of disease progression in Huntington’s disease. The study suggests that these app-based tools could also enhance the efficiency of clinical trials for the condition, potentially streamlining drug development efforts.

The findings indicate that using a smartphone application to conduct a series of digital assessments allows for more precise monitoring of changes in patients with Huntington’s disease. This approach could provide researchers with valuable data on how the disease evolves over time, offering an alternative to traditional methods used in clinical settings. By improving the ability to track disease progression, these tools may help optimize trial designs and reduce the time required to evaluate new treatments.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 9, 2025

Related posts:

Generic Drug Stability Testing: Simulating Real-World Storage Conditions Key to Maintaining Product Quality. Public Health Advocates Move to Safeguard U.S. Vaccination Policy Amid Concerns Over Health Secretary Robert F. Kennedy Jr.’s Potential Influence Omada Health Faces Profitability Challenges After 14 Years in Digital Care Industry FDA Commissioner Launches Initiative to Engage Stakeholders Through Visits to Industry and Advocacy Groups

Author

Mark Chiang